Insulet Corporation's stock gained momentum after Benchmark initiated coverage with a 'Buy' rating and a $250 price target. The company also announced the opening of its new headquarters in Riyadh, further boosting investor confidence.
Insulet (PODD) Rises on Benchmark Upgrade, Riyadh HQ Opening
Stock UpgradeMedical DevicesPODDAnalyst RatingSaudi Arabia

